Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One Raises $7M in Series B Financing Round

NEW YORK (GenomeWeb) – N-of-One said today that it has raised $7 million in a Series B financing round from Providence Ventures and Excel Venture Management.

N-of-One said it plans to use the funds to expand its efforts to develop precision medicine-based clinical decision support solutions that provide physicians with a precise and scalable approach for matching patients to treatments and clinical trials. The proceeds will also be used to expand sales and marketing efforts in the US and other strategic global markets, the company said.

"This financing round marks a new and exciting chapter for N-of-One," CEO Chris Cournoyer said in a statement. "We look forward to collaborating with our lab and health system clients to incorporate clinical data along with the patient's molecular profile to provide further refinement of treatment options."

N-of-One has signed two deals this year — with Admera Health and Macrogen — to provide clinical interpretation services for patients tested with those companies' cancer panels. The firm also signed a deal with WuXi Nextcode in November 2015 to provide clinical and scientific evidence that supports personalized treatment recommendations made on the basis of WuXi's tumor-normal sequence interpretation.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.